000 01144 a2200337 4500
005 20250517152605.0
264 0 _c20190702
008 201907s 0 0 cze d
022 _a0862-495X
040 _aNLM
_beng
_cNLM
100 1 _aSkaličková, S
245 0 0 _a[Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2].
_h[electronic resource]
260 _bKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
_c
300 _a177-179 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFullerenes
_xadministration & dosage
650 0 4 _aGenes, BRCA2
650 0 4 _aHumans
650 0 4 _aMutation
700 1 _aLöfelmann, M
700 1 _aGargulák, M
700 1 _aDočekalová, M
700 1 _aRuttkay-Nedecký, B
700 1 _aSuchý, P
700 1 _aKepinská, M
700 1 _aKizek, R
773 0 _tKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
_gvol. 30
_gno. Supplementum1
_gp. 177-179
999 _c27140980
_d27140980